HHV8 ORF50 antibody (AA 601-691)

Catalog No. ABIN729088

Product Details anti-HHV8 ORF50 Antibody

Target: HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))

Binding Specificity: AA 601-691

Reactivity: Human Herpesvirus 8 (HHV-8), Virus

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HHV8 ORF50 antibody is un-conjugated

Application: Western Blotting (WB)

Cross-Reactivity: Virus

Cross-Reactivity (Details): Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from C-terminus of HHV8 ORF50 strain GK18

Isotype: IgG

Application Details

Application Notes: ELISA 1:500-1000
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Expiry Date: 12 months

Target Details for HHV8 ORF50

Target: HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))

Alternative Name: HHV8 ORF50 (HHV8 ORF50 Products)

Target Type: Viral Protein

Background:

Synonyms: HHV8 ORF50, HHV 8, Human Herpes Virus 8, Human herpesvirus 8, Kaposi's sarcoma associated herpes virus, Kaposi's sarcoma associated herpesvirus, KSHV, replication and transcription activator, RTA

Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.

Gene ID: 4961526

UniProt: F5HCV3